On 7 July 2026, the Upper Tribunal handed down a judgment that will reverberate well beyond the orthodontics sector. In HMRC v Align Technology Switzerland GmbH & Align Technology BV [2026] UKUT 00256 (TCC), Edwin Johnson J and Judge Zaman allowed HMRC’s appeal and held that Invisalign clear aligners are not “dental prostheses” within the VAT exemption at Items 2 and 2A of Group 7, Schedule 9 to the Value Added Tax Act 1994. They are standard-rated at 20%. No exemption. No zero-rating. Just VAT at the full rate.
At first glance this looks like a technical dental-sector ruling. It isn’t. The principles at the heart of this judgment — how HMRC and the courts define the scope of VAT exemptions, what weight to give EU VAT Committee guidelines in post-Brexit UK, and what happens to businesses that treated supplies as exempt during the window of uncertainty created by the First-tier Tribunal’s opposite conclusion — are live risks for any CFO whose business operates in healthcare, medical devices, life sciences, or adjacent regulated sectors. If you have products or services near a VAT exemption boundary, this ruling is a five-alarm signal to check your classification now.
What the Case Was Actually About
Align Technology manufactures and supplies Invisalign — the removable clear plastic aligners used by orthodontists to straighten teeth. The company argued that its aligners qualified as “dental prostheses” under the VAT exemption in VATA 1994 Schedule 9, Group 7. If that argument succeeded, supplies made by dentists, dental care professionals, or dental technicians would be exempt from VAT — a significant commercial advantage for a company moving substantial volumes of product through the UK dental supply chain.
In May 2025, the First-tier Tribunal ruled in Align’s favour. It found that orthodontic appliances, including clear aligners, fell within the ordinary and purposive meaning of “dental prostheses.” Two of three specialist dictionaries consulted supported a broad reading that encompassed tooth-moving devices. The FTT decision created a window of genuine uncertainty: some dental practices and suppliers began examining whether to claim exemption on aligner supplies and apply for input tax refunds accordingly.
HMRC appealed. On 7 July 2026, the Upper Tribunal reversed the FTT entirely. The full judgment (PDF) sets out two critical steps in the UT’s reasoning:
- Statutory construction is a question of law, not fact. The UT rejected Align’s threshold argument that the meaning of “dental prostheses” was a pure question of fact, meaning only a perverse finding could be appealed. The ordinary meaning of a statutory term is always a question of law. The UT was entitled to disagree with the FTT on construction, and it did.
- Ordinary meaning: replacement, not movement. The UT held that the ordinary meaning of “dental prosthesis” requires that the item replaces missing or damaged teeth. Aligners do not replace anything. They move natural, existing teeth into new positions. That is an orthodontic function, not a prosthetic one. The aligners accordingly fall outside the exemption.
The UT also relied on EU VAT Committee guidelines and a Working Paper which pointed in the same direction — and notably rebuked the FTT for having chosen not to follow those guidelines without adequate justification. This is important post-Brexit context I return to below.
The Brexit Angle: EU VAT Committee Guidelines Are Not Dead
A point that deserves particular CFO attention: the Upper Tribunal expressly relied on EU VAT Committee guidelines as providing “a measure of additional support” for its conclusion. Post-Brexit, there is a widespread assumption in finance teams that EU-level guidance is irrelevant to UK VAT interpretation. The Upper Tribunal disagrees — at least where those guidelines align with the statutory text and the ordinary meaning of the relevant term, and where the domestic VAT provisions retain their EU VAT Directive origin.
The UK’s VAT exemptions in Schedule 9 VATA 1994 implement Article 132(1)(e) of the EU Principal VAT Directive. The legislation has not changed since Brexit. Its words still have the same origins, and those origins remain relevant to construction. If your VAT exemption claim rests on an interpretation that EU-level guidance contradicts, the UT’s approach in Align suggests that guidance will be used against you. Build that into your risk assessment.
What Happened to Businesses That Relied on the FTT Decision
Between May 2025 (FTT win for Align) and 7 July 2026 (UT reversal), there was a 14-month window in which the judicial position was, on its face, that aligners were exempt. Some advisers flagged caution. Others noted that the FTT decision at least opened the question. Any dental practice or distributor that treated aligner supplies as exempt during that window — and reclaimed input VAT on that basis — is now in a materially weakened position. HMRC will assess those businesses. The FTT decision has been set aside. There is no legal foundation for the exemption position.
This is the practical cliff edge that many CFOs miss when a favourable first-instance tribunal ruling appears. An FTT decision is not settled law. It creates a fact-pattern, not a binding precedent. Acting on it commercially — adjusting pricing, reclaiming VAT, restructuring supply agreements — before the position is confirmed at Upper Tribunal or Court of Appeal level is a calculated risk, and the Align case is a textbook illustration of what happens when that risk crystallises in the wrong direction.
The Broader CFO Risk: VAT Classification Is Not a Set-and-Forget Exercise
The dental sector is unusual in that it straddles exempt professional services, standard-rated cosmetic work, zero-rated prescription goods, and exempt dental prostheses — all of which are governed by HMRC Notice 701/57 and their interactions with VATA 1994 Schedule 9. Most CFOs in healthcare-adjacent sectors will recognise the complexity: a small change in how a product is defined, what purpose it serves, or how it is supplied can flip its VAT treatment entirely.
The Align ruling is not a one-sector story. The same “replacement vs. function” analysis the UT applied to aligners can be applied to a wide range of medical and healthcare products that sit near a VAT boundary:
- Orthotics and assistive devices — does a supportive brace “replace” a function or merely assist it?
- Wearable medical technology — continuous glucose monitors, cardiac monitors — prosthetic or diagnostic?
- Software as a Medical Device (SaMD) — where does exemption begin and standard-rating end?
- Rehabilitation equipment — is it therapeutic (exempt as part of medical care) or a taxable retail product?
HMRC has the Align playbook now. Wherever a sector has historically argued for a broad, purposive interpretation of “prosthesis” or “medical care,” expect a narrower construction to be tested. The UT has confirmed that HMRC can appeal an FTT’s statutory construction as a question of law, and the courts will look to EU Committee guidance for support.
Corrective Disclosures: The Clock Is Running
For any business that has been treating aligner supplies as exempt, the immediate questions are:
- How much output VAT has been under-declared? Work backwards from volume of supply and price points to calculate the VAT gap.
- What input VAT was overclaimed? If supplies were treated as exempt, you may have also made partial exemption adjustments or capital goods scheme adjustments based on that position.
- Is voluntary disclosure appropriate? A prompted disclosure after HMRC notifies you of an enquiry will not attract the same penalty mitigation as an unprompted disclosure made proactively. The UT judgment is public — HMRC knows who the key players are. The window for unprompted disclosure is closing.
- What do your supply contracts say about VAT? Contracts that quoted prices “plus VAT” or “VAT-exclusive” may allow VAT to be recovered from customers. Contracts silent on VAT, or those that set an all-inclusive price, may leave your business bearing the additional cost.
Claritax News has noted that any dental practice that acted on the FTT decision should treat its position as “materially weakened” and consider making corrective disclosures. That is the right instinct. Acting quickly, with full documentation of the position taken and the legal basis for it, gives your business the best chance of minimising penalties under Finance Act 2007, Schedule 24 (errors in taxpayer documents).
Input VAT Recovery: The Hidden Flip
There is a less-discussed upside buried in the Align ruling that some CFOs will miss. If supplies of aligners are standard-rated rather than exempt, suppliers can recover input VAT on the costs directly attributable to those supplies. Businesses that treated their aligner supply chain as making exempt supplies — and accordingly restricted input tax recovery on stock, manufacturing costs, overheads, or logistics under partial exemption rules — may now have an input VAT recovery claim that runs backwards through historic VAT periods, subject to the four-year cap.
This is the kind of structural VAT review that finance teams rarely flag proactively but that can represent material cash recovery. If your business is in the dental or medical device supply chain and you have been applying partial exemption restrictions on the basis that supplies were exempt, instruct your VAT adviser to recalculate your recovery position from the ground up. The Align ruling changes the input tax denominator.
The Court of Appeal: Not Over Yet
The VATupdate commentary noted that a Court of Appeal application remains possible. Align has grounds: the UT’s reasoning on EU Committee guidelines is bold, and a purposive argument has not been fully exhausted. However, the UT’s statutory construction analysis — the ordinary meaning of “prosthesis” as replacement, not movement — is grounded and robust. A Court of Appeal challenge faces a high bar.
For business planning purposes, treat the UT decision as the operative position unless and until a Court of Appeal stay is granted. Do not defer corrective action on the assumption that Align will appeal and win. The consequences of inaction — assessments, interest, and potentially enhanced penalties — are far worse than the cost of acting now and potentially reversing course later.
Six CFO Actions Following the Align Ruling
Whether you are in the dental sector directly or operating adjacent to it, here is the structured response your finance function should run now:
- Audit your product VAT classification register. Every product or service line near a VAT exemption boundary needs a fresh classification review. The Align ruling signals HMRC will not accept “it functions like a prosthesis” — it wants “it is a prosthesis.” Function and form are not the same test.
- Calculate the VAT gap for any affected supplies. Identify the volume and value of supplies that may have been wrongly treated as exempt since May 2025. Quantify the output VAT underdeclared and any associated input tax overclaimed under partial exemption.
- Take legal advice on unprompted disclosure timing. The longer you wait, the higher the risk that HMRC opens an enquiry, converting your disclosure from unprompted (best mitigation) to prompted (reduced mitigation). Time matters here.
- Review supply contracts for VAT pass-through provisions. Before disclosing or paying VAT, understand whether your contracts allow you to add VAT to the contract price or whether the VAT cost falls on your margin. The legal position on VAT and contract terms is nuanced — VATA 1994 s.19 and associated regulations determine the consideration, not the contract price alone.
- Recalculate partial exemption positions and input VAT recovery. Standard-rated supplies improve input tax recovery. If your partial exemption position was calculated on the basis of exempt aligner supplies, recalculate and identify any historic under-recovery that can be claimed back within the four-year cap.
- Monitor for Court of Appeal developments and HMRC guidance updates. HMRC Notice 701/57 may be updated to reflect the UT ruling. Watch for Revenue & Customs Briefs that address the transitional period and confirm HMRC’s approach to assessments on businesses that relied on the FTT decision.
The Takeaway: Exemptions Belong Under the Microscope
The Align ruling is a reminder that VAT exemptions are narrow by design and construed accordingly by the courts. The FTT’s broader, dictionary-driven approach — finding that two of three specialist dictionaries supported a wider meaning of “prosthesis” — was rejected precisely because statutory construction is a discipline, not a dictionary exercise. The ordinary meaning of the word in the context of the legislation is what matters, and that meaning is constrained by the purpose and structure of the exemption.
For CFOs in healthcare, life sciences, medical devices, dental supply, or any sector that relies on a VAT exemption for commercial margin management, the lesson is operational: your VAT classification is not settled law until the courts say it is. FTT decisions create uncertainty, not certainty. Business decisions made on the back of an FTT win — pricing adjustments, exemption claims, input tax reclaims, structural supply chain changes — carry the full risk of reversal. Size that risk correctly. Have a reversal plan. And if you are sitting on a position that an FTT created but the Upper Tribunal has now closed, act fast.